Medicare Enrolled

Dr. Mario Celaya, P.A.

Physician Assistant · Lindsay, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
833 SEQUOIA AVE STE B, Lindsay, CA 93247
5595621361
In practice since 2007 (19 years)
NPI: 1124173786 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Celaya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Celaya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Celaya

Dr. Mario Celaya is a physician assistant in Lindsay, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Celaya performed 189 Medicare services across 127 unique beneficiaries.

Between the years covered by Open Payments, Dr. Celaya received a total of $8,800 from 35 pharmaceutical and/or device companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Celaya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 49% volume in CA $8,800 industry payments

Medicare Practice Summary

Medicare Utilization ↗
189
Medicare services
Top 49% in CA for physician assistant
127
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
66 $10 $48
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
34 $1 $10
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
33 $1 $10
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
25 $3 $6
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $27 $68
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
11 $33 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,800
Total received (2021-2024)
Avg $2,200/year across 4 years
Top 3% in CA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
446
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,800 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,506
2023
$1,931
2022
$1,809
2021
$2,553

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$634
Amgen Inc.
$582
Lilly USA, LLC
$462
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
Otsuka America Pharmaceutical, Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$99
ANI Pharmaceuticals, Inc.
$78
Novo Nordisk Inc
$77
Merck Sharp & Dohme LLC
$42
ABBVIE INC.
$42
Agile Therapeutics, Inc.
$36
Phathom Pharmaceuticals, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$20
Baxter Healthcare
$18
PFIZER INC.
$18
Exact Sciences Corporation
$18
IRONWOOD PHARMACEUTICALS, INC
$17
Top 3 companies account for 67.0% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$1,842
Novo Nordisk Inc
$1,264
Amgen Inc.
$964
Lilly USA, LLC
$882
Corcept Therapeutics
$466
Otsuka America Pharmaceutical, Inc.
$446
Boehringer Ingelheim Pharmaceuticals, Inc.
$418
Sunovion Pharmaceuticals Inc.
$341
AbbVie Inc.
$234
Sumitomo Pharma America, Inc.
$210
ABBVIE INC.
$207
Merck Sharp & Dohme LLC
$189
IDORSIA PHARMACEUTICALS US INC
$172
Janssen Pharmaceuticals, Inc
$160
MannKind Corporation
$152
Novartis Pharmaceuticals Corporation
$146
Bayer Healthcare Pharmaceuticals Inc.
$115
ANI Pharmaceuticals, Inc.
$78
Merck Sharp & Dohme Corporation
$58
Baxter Healthcare
$43
Amarin Pharma Inc.
$41
GlaxoSmithKline, LLC.
$40
Axsome Therapeutics, Inc.
$38
Eisai Inc.
$36
Agile Therapeutics, Inc.
$36
PFIZER INC.
$36
SANOFI-AVENTIS U.S. LLC
$29
Mylan Specialty L.P.
$27
Phathom Pharmaceuticals, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$20
Cranial Technologies, Inc
$20
Exact Sciences Corporation
$18
IRONWOOD PHARMACEUTICALS, INC
$17
Ironwood Pharmaceuticals, Inc
$16
Alkermes, Inc.
$16
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · Auvelity · BELSOMRA · BEXSERO · BREZTRI · CREON · Cologuard Collection Kit · Crysvita · Dayvigo · Doc Band · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GEMTESA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · Linzess · MOUNJARO · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · PURIFIED CORTROPHIN GEL · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · Twirla · UBRELVY · VERQUVO · VIVITROL · VOQUEZNA · VRAYLAR · Vascepa · Wegovy · XARELTO · Yupelri · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for physician assistant in CA.

Looking for a physician assistant in Lindsay?
Compare physician assistants in the Lindsay area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
156
Per 100K population
32.8
County median income
$69,489
Nearest hospital
PORTERVILLE DEVELOPMENTAL CENTER
10.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Celaya is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Celaya experienced with drug injection, under skin or into muscle?
Based on Medicare claims data, Dr. Celaya performed 66 drug injection, under skin or into muscle services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Celaya receive payments from pharmaceutical companies?
Yes. Dr. Celaya received a total of $8,800 from 35 companies across 446 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Celaya's costs compare to other physician assistants in Lindsay?
Dr. Celaya's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Celaya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →